Peel Hunt reissued their add rating on shares of UDG Healthcare (LON:UDG) in a research report sent to investors on Tuesday morning. Peel Hunt currently has a GBX 860 ($11.52) price objective on the stock.

Several other analysts have also issued reports on the stock. Numis Securities lowered shares of UDG Healthcare to a reduce rating and set a GBX 765 ($10.25) target price on the stock. in a research report on Thursday, November 9th. N+1 Singer boosted their price target on shares of UDG Healthcare from GBX 770 ($10.31) to GBX 841 ($11.26) and gave the stock a hold rating in a research report on Wednesday, November 1st. Liberum Capital restated a hold rating and set a GBX 884 ($11.84) price target on shares of UDG Healthcare in a research report on Wednesday, November 15th. Finally, Jefferies Group boosted their price target on shares of UDG Healthcare from GBX 830 ($11.12) to GBX 855 ($11.45) and gave the stock a hold rating in a research report on Wednesday, October 4th. One investment analyst has rated the stock with a sell rating and six have assigned a hold rating to the stock. The stock has an average rating of Hold and an average target price of GBX 831.43 ($11.13).

Shares of UDG Healthcare (UDG) opened at GBX 857 ($11.48) on Tuesday. UDG Healthcare has a 52-week low of GBX 632.50 ($8.47) and a 52-week high of GBX 963 ($12.90).

COPYRIGHT VIOLATION WARNING: “UDG Healthcare (UDG) Given “Add” Rating at Peel Hunt” was first reported by Daily Political and is the property of of Daily Political. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The original version of this news story can be accessed at https://www.dailypolitical.com/2017/12/02/udg-healthcare-udg-given-add-rating-at-peel-hunt.html.

UDG Healthcare Company Profile

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.

Analyst Recommendations for UDG Healthcare (LON:UDG)

Receive News & Ratings for UDG Healthcare plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UDG Healthcare plc and related companies with MarketBeat.com's FREE daily email newsletter.